CRISPR/Cas9‐Mediated Mutagenesis to Validate the Synergy Between PARP1 Inhibition and Chemotherapy in BRCA1 ‐Mutated Breast Cancer Cells

Bioengineering & Translational Medicine
doi 10.1002/btm2.10152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

CRISPR/Cas9-mediated Targeted Mutagenesis in Grape

PLoS ONE
Multidisciplinary
2017English

Genomic Access to Monarch Migration Using TALEN and CRISPR/Cas9-Mediated Targeted Mutagenesis

G3: Genes, Genomes, Genetics
MedicineGeneticsMolecular Biology
2016English

CRISPR/Cas9-mediated Mutagenesis of lncRNA1459 Alters Tomato Fruit Ripening

Plant Journal
Plant ScienceGeneticsCell Biology
2018English

CRISPR/Cas9-Mediated SlNPR1 Mutagenesis Reduces Tomato Plant Drought Tolerance

BMC Plant Biology
Plant Science
2019English

Robust CRISPR/Cas9-Mediated Tissue Specific Mutagenesis Reveals Gene Redundancy and Perdurance in Drosophila

Genetics
Genetics
2018English

Targeted Mutagenesis in Wheat Microspores Using CRISPR/Cas9

Scientific Reports
Multidisciplinary
2018English

Efficient Targeted Mutagenesis in Potato by the CRISPR/Cas9 System

Plant Cell Reports
MedicinePlant ScienceAgronomyCrop Science
2015English

Corrigendum: CRISPR/Cas9-mediated Efficient and Heritable Targeted Mutagenesis in Tomato Plants in the First and Later Generations

Scientific Reports
Multidisciplinary
2017English

Maximizing Mutagenesis With Solubilized CRISPR-Cas9 Ribonucleoprotein Complexes

Development (Cambridge)
Developmental BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy